Skip to main content
Premium Trial:

Request an Annual Quote

ABI to Debut Avian Assays in Europe This Summer; Firm Chatting With FDA

This update includes comments from an ABI spokesperson.
 
NEW YORK (GenomeWeb News) — Applied Biosystems plans to make and market pathogen-detecting assay kits through a collaboration with the UK government’s Veterinary Laboratories Agency, the company said today.
 
Under the agreement, ABI will build one test kit for avian influenza and one for Newcastle disease, ABI said. Both kits, which the company said are designed to help doctors detect bird-borne diseases, will be marketed widely in Europe, Asia and Africa, but will not be available in the US.  
 
VLA will validate the assays, ABI said.
 
ABI said the VLA used the kits to confirm that the 2,600 turkeys that recently died in Suffolk, England, were killed by the H5N1 strain of avian flu, and were subsequently used in a follow-up survey of the region’s population of wild birds.
 
Early detection allowed for a swift containment response in this case, the company said, adding that the goal of the collaboration is to make the assays available for “the same type of early warning detection in various countries.
 
Financial terms of the agreement were not released.
 
ABI Europe spokesman Tony Hardware said the company expects the tests to be available in the late summer.
 
Hardware said the company expects to receive European CE Mark certification for the kits “rather quickly,” and should be deploying in Europe sometime around August. The assays will be available in Africa and Asia sometime after that.
 
ABI is “involved in discussions” with US officials about seeking FDA approval to market the products in the US, Hardware said, but he could not estimate a timetable for a US deployment.

The Scan

Unique Germline Variants Found Among Black Prostate Cancer Patients

Through an exome sequencing study appearing in JCO Precision Oncology, researchers have found unique pathogenic or likely pathogenic variants within a cohort of Black prostate cancer patients.

Analysis of Endogenous Parvoviral Elements Found Within Animal Genomes

Researchers at PLOS Biology have examined the coevolution of endogenous parvoviral elements and animal genomes to gain insight into using the viruses as gene therapy vectors.

Saliva Testing Can Reveal Mosaic CNVs Important in Intellectual Disability

An Australian team has compared the yield of chromosomal microarray testing of both blood and saliva samples for syndromic intellectual disability in the European Journal of Human Genetics.

Octopus Brain Complexity Linked to MicroRNA Expansions

Investigators saw microRNA gene expansions coinciding with complex brains when they analyzed certain cephalopod transcriptomes, as they report in Science Advances.